Aim: to investigate the association of EDF factors: endothelin 1 (ET1), endothelial NO-synthase (eNOS), nitric oxide (NO), tumor necrosis factor (TNFα), and diene conjugates (DC) with severity of type 2 diabetes.
Material and methods. Data were used for 152 hospital patients with type 2 diabetes at the age from 34 to 80 years (53.9±8.4 years). Women were 95 (62.5%), men – 57 (37.5%). According to the degree of severity of patients was divided into three groups: 1st (37.5% of patients) – the average stage in the compensation stage (HbA1s 7-9%), 2nd (41.4%) – the average stage in the stage of decompensation (HbA1s more than 9%), 3rd (21,1%) – a severe degree in the stage of decompensation. The control group included 95 practically healthy individuals. The plasma levels of the blood were determined by the enzyme-linked method: ЕТ1 (Biomedica Immunoassays, Austria), eNOS (BCM Diagnostics, USA) і TNFα (Bender Medsystems, Austria). The level of blood NO and DC were determined biochemically (spectrophotometer Specord, Germany). Statistica 10 (StatSoft, Inc., USA) was used to statistically process the data obtained.
Results. Levels of EDF factors depended on the severity of DM 2 type. Thus, the level of ETI in patients exceeded control in 3.7-4.7 times (p<0.001) with the maximum values in the 2nd and 3rd groups; also increased blood levels of NO (1.4-1.5 times; p<0.001). The highest increase was observed in TNFα levels (4.2-6.5 times; p<0.001) and DC (2.3-2.7 times; p<0.001). The blood content of eNOS in the patients' groups was lower when compared with control (1.3-1.9 times; p<0.001).
Conclusion. Factors of EDF are closely linked with clinical and laboratory indicators of severity of DM 2 type, which highlights them in the pathogenesis of the disease.

diabetes mellitus 2 type, severity, endothelin 1, nitric oxide, eNOS, TNFα, diene conjugates

Pankiv VI. [Diabetes mellitus: diagnostic criteria, etiology and pathogenesis]. International Endocrinology Journal.2013;8(56):53-64. In Ukrainian

Type 2 Diabetes Complications. Web-resource: www.endocrineweb.com/ conditions/type-2-diabetes.

Yan ZP, Ma JX. Risk factors for diabetic retinopathy in northern Chinese patients with type 2 diabetes mellitus. Int J Ophthalmol. 2016;9(8):1194-1199. doi: 10.18240/ijo.2016.08.17.

Pi X, Xie L, Patterson C. Emerging Roles of Vascular Endothelium in Metabolic Homeostasis. Circ Res. 2018 Aug 3;123(4):477-494. doi: 10.1161/CIRCRESAHA.118.313237.

Sinyachenko OV, Ziablitsev SV, Chernobryvtsev PA. [Endothelial dysfunction in glomerulonephritis]. Donetsk: New World, 2006:152. In Russian

Cutiongco MFA, Chua BMX, Neo DJH, Rizwan M, Yim EKF. Functional differences between healthy and diabetic endothelial cells on topographical cues. Biomaterials. 2018 Jan; 153:70-84. doi: 10.1016/j.biomaterials.2017.10.037.

Blum A., Socea D., Sirchan R. Vascular responsiveness in type 2 diabetes mellitus (T2DM). QJM. 2016 Dec;109(12):791-796. doi: 10.1093/qjmed/hcw081.

Sinyachenko OV, Ziablitsev SV, Chernobrivtsev PA. [The state of the endothelium and the morphological changes in the structures of the kidney during experimental glomerulonephritis]. Pathology. 2007; 4(1):23-26. In Russian

Carrizzo A, Izzo C, Oliveti M, Alfano A, Virtuoso N, Capunzo M, Di Pietro P, Calabrese M, De Simone E, Sciarretta S, Frati G, Migliarino S, Damato A, Ambrosio M, De Caro F, Vecchione C. The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation. Int J Mol Sci. 2018 Sep 28;19(10). pii: E2968. doi: 10.3390/ijms19102968.

Babik B, Peták F, Agócs S, Blaskovics I, Alács E, Bodó K, Südy R. [Diabetes mellitus: endothelial dysfunction and changes in hemostasis]. Orv Hetil. 2018 Aug;159(33):1335-1345. doi: 10.1556/650.2018.31130. In Hungarian

Polovina MM, Potpara TS. Endothelial dysfunction in metabolic and vascular disorders. Postgrad Med. 2014 Mar; 126 (2): 38-53. doi: 10.3810/pgm.2014.03.2739.

Raminderjit Kaur, Manpreet Kaur, and Jatinder Singhcorresponding. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol. 2018; 17: 121. doi: [10.1186/s12933-018-0763-3]

Bermejo-Martin JF, Martín-Fernandez M, López-Mestanza C, Duque P, Almansa R. Shared Features of Endothelial Dysfunction between Sepsis and Its Preceding Risk Factors (Aging and Chronic Disease). J Clin Med. 2018 Oct 30;7(11). pii: E400. doi: 10.3390/jcm7110400.

Knapp M, Tu X, Wu R. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacol Sin. 2018 Jun 4. doi: 10.1038/s41401-018-0042-6.

Ziablitsev SV, Mokrii VY, Cristal MV. The value of polimorfism Pro12Ala gene in violation of lipid peroxidation and antioxidant protection in patient with type 2 diabetes mellitus. Journal of Education, Health and Sport formely of Health Sciences. 2016;6(9):626-636.

Lian K, Guo X, Huang Q, Tan Z, Xia C, Wang R, Yi F, Li W, Liu J, Li Y, Guo S, Wang H, Ji Q, Tao L. Reduction Levels and the Effects of High-Molecular-Weight Adiponectin via AMPK/eNOS in Chinese Type 2 Diabetes. Exp Clin Endocrinol Diabetes. 2016 Oct;124(9):541-547. doi: 10.1055/s-0042-109262.